Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Cancer . Primer of the molecular biology of cancer : principles & practice of oncology / / editors, Vincent T. DeVita, Jr., Theodore S. Lawrence, Steven A. Rosenberg
| Cancer . Primer of the molecular biology of cancer : principles & practice of oncology / / editors, Vincent T. DeVita, Jr., Theodore S. Lawrence, Steven A. Rosenberg |
| Edizione | [Third edition.] |
| Pubbl/distr/stampa | Philadelphia : , : Wolters Kluwer, , [2021] |
| Descrizione fisica | 1 online resource (1011 pages) |
| Disciplina | 616.994 |
| Soggetto topico |
Cancer - Molecular aspects
Cancer - Genetic aspects Neoplasms - genetics |
| ISBN | 1-9751-4913-0 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910795673203321 |
| Philadelphia : , : Wolters Kluwer, , [2021] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cancer of the skin / / [editors], Vincent T. DeVita, Jr., MD, et al
| Cancer of the skin / / [editors], Vincent T. DeVita, Jr., MD, et al |
| Pubbl/distr/stampa | Philadelphia : , : Wolters Kluwer, , [2016] |
| Descrizione fisica | 1 online resource (various pagings) : illustrations |
| Disciplina | 616.99/477 |
| Soggetto topico | Skin - Tumors |
| ISBN | 1-4963-3797-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Part I. Principles of Oncology -- 1. The Cancer Genome -- 2. Hallmarks of Cancer: An Organizing Principle for Cancer Medicine -- 3. Molecular Methods in Cancer -- Part II. Etiology and Epidemiology of Cancer -- Section 1. Etiology Of Cancer -- 4. Tobacco -- 5. Oncogenic Viruses -- 6. Inflammation -- 7. Chemical Factors -- 8. Physical Factors -- 9. Dietary Factors -- 10. Obesity and Physical Activity -- Section 2. Epidemiology Of Cancer -- 11. Epidemiologic Methods -- 12. Trends in United States Cancer Mortality -- Part III. Cancer Therapeutics -- 13. Essentials of Radiation Therapy -- 14. Cancer Immunotherapy -- 15. Pharmacokinetics and Pharmacodynamics of Anticancer Drugs --
16. Pharmacogenomics -- 17. Alkylating Agents -- 18. Platinum Analogs -- 19. Antimetabolites -- 20. Topoisomerase Interactive Agents -- 21. Antimicrotubule Agents -- 22. Kinase Inhibitors as Anticancer Drugs -- 23. Histone Deacetylase Inhibitors and Demethylating Agents -- 24. Proteasome Inhibitors -- 25. Poly (ADP-ribose) Polymerase Inhibitors -- 26. Miscellaneous Chemotherapeutic Agents -- 27. Hormonal Agents -- 28. Antiangiogenesis Agents -- 29. Monoclonal Antibodies -- 30. Assessment of Clinical Response -- Part IV. Cancer Prevention and Screening -- 31. Tobacco Use and the Cancer Patient -- 32. Role of Surgery in Cancer Prevention -- 33. Cancer Risk-Reducing Agents -- 34. Cancer Screening -- 35. Genetic Counseling -- Part V. Cancer of the Skin -- 36. Cancer of the Skin -- 37. Molecular Biology of Cutaneous Melanoma -- 38. Cutaneous Melanoma -- 39. Genetic Testing in Skin Cancer. |
| Record Nr. | UNINA-9910446331503321 |
| Philadelphia : , : Wolters Kluwer, , [2016] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cancer of the thoracic cavity : from Cancer principles & practice of oncology / / [edited by] Vincent T. DeVita, Jr., MD, et al
| Cancer of the thoracic cavity : from Cancer principles & practice of oncology / / [edited by] Vincent T. DeVita, Jr., MD, et al |
| Edizione | [10th edition.] |
| Pubbl/distr/stampa | Philadelphia : , : Wolters Kluwer, , [2016] |
| Descrizione fisica | 1 online resource (1,356 pages) : illustrations (chiefly color) |
| Disciplina | 616.99/494 |
| Soggetto topico |
Chest - Cancer
Lungs - Cancer |
| ISBN | 1-4963-3824-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Part I. Principles of Oncology -- 1. The Cancer Genome -- 2. Hallmarks of Cancer: An Organizing Principle for Cancer Medicine -- 3. Molecular Methods in Cancer -- Part II. Etiology and Epidemiology of Cancer -- Section 1. Etiology of Cancer -- 4. Tobacco -- 5. Oncogenic Viruses -- 6. Inflammation -- 7. Chemical Factors -- 8. Physical Factors -- 9. Dietary Factors -- 10. Obesity and Physical Activity -- Section 2. Epidemiology of Cancer -- 11. Epidemiologic Methods -- 12. Trends in United States Cancer Mortality -- Part III. Cancer Therapeutics -- 13. Essentials of Radiation Therapy -- 14. Cancer Immunotherapy -- 15. Pharmacokinetics and Pharmacodynamics of Anticancer Drugs -- 16. Pharmacogenomics -- 17. Alkylating Agents -- 18. Platinum Analogs -- 19. Antimetabolites -- 20. Topoisomerase Interactive Agents -- 21. Antimicrotubule Agents -- 22. Kinase Inhibitors as Anticancer Drugs -- 23. Histone Deacetylase Inhibitors and Demethylating Agents -- 24. Proteasome Inhibitors -- 25. Poly (ADP-ribose) Polymerase Inhibitors --
26. Miscellaneous Chemotherapeutic Agents -- 27. Hormonal Agents -- 28. Antiangiogenesis Agents -- 29. Monoclonal Antibodies -- 30. Assessment of Clinical Response -- Part IV. Cancer Prevention and Screening -- 31. Tobacco Use and the Cancer Patient -- 32. Role of Surgery in Cancer Prevention -- 33. Cancer Risk-Reducing Agents -- 34. Cancer Screening -- 35. Genetic Counseling -- Part V. Cancer of the Thoracic Cavity -- 36. Molecular Biology of Lung Cancer -- 37. Non-Small Cell Lung Cancer -- 38. Small Cell and Neuroendocrine Tumors of the Lung -- 39. Neoplasms of the Mediastinum -- 40. Benign and Malignant Mesothelioma -- 41. Peritoneal Metastases and Peritoneal Mesothelioma. |
| Record Nr. | UNINA-9910446337403321 |
| Philadelphia : , : Wolters Kluwer, , [2016] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
DeVita, Hellman, and Rosenberg's cancer : principles & practice of oncology Primer of the molecular biology of cancer / / editors, Vincent T. DeVita, Jr., Theodore S. Lawrence, Steven A. Rosenberg
| DeVita, Hellman, and Rosenberg's cancer : principles & practice of oncology Primer of the molecular biology of cancer / / editors, Vincent T. DeVita, Jr., Theodore S. Lawrence, Steven A. Rosenberg |
| Edizione | [Third edition.] |
| Pubbl/distr/stampa | Philadelphia : , : Wolters Kluwer, , [2021] |
| Descrizione fisica | 1 online resource (1011 pages) |
| Disciplina | 616.994 |
| Soggetto topico |
Cancer - Molecular aspects
Cancer - Genetic aspects Neoplasms - genetics |
| ISBN | 1-9751-4913-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti |
Cancer. Primer of the molecular biology of cancer : principles & practice of oncology
Primer of the molecular biology of cancer Cancer : principles & practice of oncology |
| Record Nr. | UNINA-9910824427903321 |
| Philadelphia : , : Wolters Kluwer, , [2021] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
DeVita, Hellman, and Rosenberg's cancer : principles & practice of oncology / / editors, Vincent T. DeVita, Jr., Theodore S. Lawrence, Steven A. Rosenberg
| DeVita, Hellman, and Rosenberg's cancer : principles & practice of oncology / / editors, Vincent T. DeVita, Jr., Theodore S. Lawrence, Steven A. Rosenberg |
| Edizione | [11thed.] |
| Pubbl/distr/stampa | Philadelphia, Pennsylvania : , : Wolters Kluwer, , [2019] |
| Descrizione fisica | xli, 2390 pages : illustrations (some colour), colour portraits ; ; 29 cm |
| Disciplina | 616.994 |
| Soggetto topico |
Cancer
Neoplasms Oncology |
| ISBN |
1-4963-9464-X
1-4963-9465-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910511646503321 |
| Philadelphia, Pennsylvania : , : Wolters Kluwer, , [2019] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
DeVita, Hellman, and Rosenberg's cancer : principles & practice of oncology / / [edited by] Vincent T. DeVita Jr., Theodore S. Lawrence, Steven A. Rosenberg
| DeVita, Hellman, and Rosenberg's cancer : principles & practice of oncology / / [edited by] Vincent T. DeVita Jr., Theodore S. Lawrence, Steven A. Rosenberg |
| Edizione | [10th ed.] |
| Pubbl/distr/stampa | Philadelphia, : Wolters Kluwer Health/Lippincott Williams & Wilkins, 2015 |
| Descrizione fisica | 1 online resource (2280 pages) |
| Disciplina | 616.99/4 |
| Altri autori (Persone) |
DeVitaVincent T., Jr., <1935->
LawrenceTheodore S RosenbergSteven A |
| Soggetto topico |
Cancer
Oncology Neoplasms |
| ISBN |
1-4698-9455-6
1-4963-2467-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cancer Principles & -- Practice of Oncology -- CONTRIBUTORS -- PREFACE -- Acknowledgments -- CONTENTS -- PART I Principles of Oncology -- 1 Cancer Genome -- introduction -- CANCER GENES AND THEIR MUTATIONS -- IDENTIFICATION OF CANCER GENES -- SOMATIC ALTERATION CLASSES DETECTED BY CANCER GENOME ANALY SIS -- PATHWAY-ORIENTED MODELS OF CANCER GENOME ANALY SIS -- NETWORKS OF CANCER GENOME PROJECTS -- THE GENOMIC LANDSCAPE OF CANCERS -- INTEGRATIVE ANALY SIS OF CANCER GENOMICS -- THE CANCER GENOME AND THE NEW TAXONOMY OF TUMORS -- CANCER GENOMICS AND DRUG RESISTANCE -- PERSPECTIVES OF CANCER GENOME ANALY SIS -- Acknowledgments -- 2 Hallmarks of Cancer: An Organizing Principle for Cancer Medicine -- Introduction -- HALLMARK CAPABILITIES, IN ESSENCE -- TWO UBIQUITOUS CHARACTERISTICS FACILITATE THE ACQUISITION OF HALLMARK CAPABILITIES -- THE CONSTITUENT CELL TYPES OF THE TUMOR MICROENVIRONMENT -- THERAPEUTIC TARGETING OF THE HALLMARKS OF CANCER -- CONCLUSION AND A VISION FOR THE FUTURE -- Acknowledgment -- 3 Molecular Methods in Cancer -- Applications of Molecular Diagnostics in Oncology -- The Clinical Molecular Diagnostics Laboratory: Rules and Regulations -- Specimen Requirements for Molecular Diagnostics -- Molecular Diagnostics Testing Process -- Technologies -- PART II Etiology and Epidemiology of Cancer -- Section 1 Etiology of Cancer -- 4 Tobacco -- introduction -- EPIDEMIOLOGY OF TOBACCO AND CANCER -- CARCINOGENS IN TOBACCO PRODUCTS AND PROCESSES OF CANCER DEVELOPMENT -- 5 Oncogenic Viruses -- PRINCIPLES OF TUMOR VIROLOGY -- PAPILLOMAVIRUSES -- POLYOMAVIRUSES -- EPSTEIN-BARR VIRUS -- KAPOSI's SARCOMA HERPESVIRUS -- ANIMAL AND HUMAN RETRO VIRUSES -- HEPATITIS VIRUSES -- CONCLUSION -- 6 Inflammation -- Introduction -- MOLECULAR BASIS OF INFLAMMATION -- ROLE OF INFLAMMATION IN TRANSFORMATION -- ROLE OF INFLAMMATION IN SURVIVAL.
ROLE OF INFLAMMATION IN PROLIF ERATION -- ROLE OF INFLAMMATION IN INVASION -- ROLE OF INFLAMMATION IN ANGIOGENESIS -- ROLE OF INFLAMMATION IN META STASIS -- EPIGENETIC CHANGES AND INFLAMMATION -- ROLE OF INFLAMMATION IN CANCER DIAGNOSIS -- INFLAMMATION AND GENOMICS -- INFLAMMATION AND TARGETED THERAPIES -- CONCLUSIONS -- 7 Chemical Factors -- Introduction -- THE NAT URE OF CHEMICAL CARCINOGENS: CHEMISTRY AND META BOLISM -- ANIMAL MODEL SYSTEMS AND CHEMICAL CARCINOGENESIS -- MOLECULAR EPIDEMIOLOGY, CHEMICAL CARCINOGENESIS, AND CANCER RISK IN HUMAN POPULATION S -- ARISTOLO CHIC ACID AND UROT HELIAL CANCERS AS A MODEL FOR IDENTIFYING HUMAN CARCINOGENS -- 8 Physical Factors -- INTRODUCTION -- IONIZING RADIATION -- ULTRAVIOLET LIGHT -- RADIOFREQUENCY AND MICROWAVE RADIATION -- ELECTROMAGNETIC FIELDS -- ASBESTOS -- NANOPARTICLES -- 9 Dietary Factors -- Introduction -- METHODOLOGIC CHALLENGES -- THE ROLE OF INDIVIDUAL FOOD AND NUTRIENTS IN CANCER ETIOLOGY -- OTHER FOODS AND NUTRIENTS -- DIETARY PATTERNS -- DIET DURING THE EARLY PHASES OF LIFE -- DIET AFTER A DIAGNOSIS OF CANCER -- SUMMARY -- LIMITATIONS -- FUTURE DIRECTIONS -- RECOMMENDATIONS -- 10 Obesity and Physical Activity -- INTRODUCTION -- BREAST CANCER -- COLON AND RECTAL CANCER -- ENDOMETRIAL CANCER -- ADENOCARCINOMA OF THE ESOPHAGUS -- KIDNEY/RENAL CELL CANCER -- PANCREATIC CANCER -- GALLBLADDER CANCER -- NON-HODGKIN LYMPHOMA -- PROSTATE CANCER -- LUNG CANCER -- OVARIAN CANCER -- CONCLUSIONS -- Section 2 Epidemiology of Cancer -- 11 Epidemiologic Methods -- Introduction -- ANALYTICAL STUDIES -- INTERPRETATION OF EPIDEMIOLOGIC FINDINGS -- CANCER OUTCOMES RESEARCH -- MOLECULAR EPIDEMIOLOGY -- 12 Trends in United States Cancer Mortality -- INTRODUCTION -- CANCER SURVEILLANCE SYSTEMS -- MAKING SENSE OF CANCER TRENDS -- TRENDS IN CANCER RISK FACTORS AND SCREENING -- CANCER INCIDENCE AND MORTALITY. PREDICTING FUTURE CANCER TRENDS -- PART III Cancer Therapeutics -- 13 Essentials of Radiation Therapy -- INTRODUCTION -- BIOLOGIC ASPECTS OF RADIATION ONCOLOGY -- FACTORS THAT AFFECT RADIATION RESPONSE -- DRUGS THAT AFFECT RADIATION SENSITIVITY -- RADIATION PHYSICS -- TREATMENT PLANNING -- OTHER TREATMENT MODALITIES -- CLINICAL APPLICATIONS OF RADIATION THERAPY -- TREATMENT INTENT -- FRACTIONATION -- ADVERSE EFFECTS -- PRINCIPLES OF COMBINING ANTICANCER AGENTS WITH RADIATION THERAPY -- 14 Cancer Immunotherapy -- Introduction -- HUMAN TUMOR ANTIGENS -- HUMAN CANCER IMMUNOTHERAPIES -- 15 Pharmacokinetics and Pharmacodynamics of Anticancer Drugs -- INTRODUCTION -- PHARMACOKINETIC CONCEPTS -- PHARMACODYNAMIC CONCEPTS -- VARIABILITY IN PHARMACOKINETICS/ PHARMACODYNAMICS -- DOSE-ADAPTATION USING PHARMACOKINETIC/PHARMACODYNAMIC PRINCIPLES -- 16 Pharmacogenomics -- Introduction -- PHARMACOGENOMICS OF TUMOR RESPONSE -- PHARMACOGENOMICS OF CHEMOTHERAPY DRUG TOXICITY -- CONCLUSIONS AND FUTURE DIRECTIONS -- 17 Alkylating Agents -- PERSPECTIVES -- CHEMISTRY -- CLASSIFICATION -- CLINICAL PHARMACOKINETICS/ PHARMACODYNAMICS -- THERAPEUTIC USES -- TOXICITIES -- COMPLICATIONS WITH HIGH-DOSE ALKYLATING AGENT THERAPY -- ALKYLATING AGENT-STEROID CONJUGATES -- DRUG RESISTANCE AND MODULATION -- RECENT DEVELOPMENTS -- 18 Platinum Analogs -- Introduction -- HISTORY -- PLATINUM CHEMISTRY -- PLATINUM COMPLEXES AFTER CISPLATIN -- MECHANISM OF ACTION -- CELLULAR RESPONSES TO PLATINUM-INDUCED DNA DAMAGE -- IS DNA THE ONLY TARGET? -- MECHANISMS OF RESISTANCE -- CLINICAL PHARMACO LOGY -- FORMULATION AND ADMINISTRATION -- TOXICITY -- 19 Antimetabolites -- ANTIFOLATES -- 5-FLUOROPYRIMIDINES -- CAPECITABINE -- CYTARABINE -- GEMCITABINE -- 6-THIOPURINES -- FLUDARABINE -- CLADRIBINE -- CLOFARABINE -- 20 Topoisomerase Interactive Agents. CLASSIFICATION, BIOCHEMICAL, AND BIOLOGIC FUNCTIONS OF TOPOISOMERASES -- TOPOISOMERASE INHIBITORS AS INTERFACIAL POISONS -- Topoisomerase I Inhibitors : Camptothecins and Beyond -- TOPOISOMERASE II INHIBITORS: INTERCALATORS AND NONINTERCALATORS -- THERAPY-RELATED SECONDARY ACUTE LEUKEMIA -- FUTURE DIRECTIONS -- 21 Agents -- MICROTUBULES -- TAXANES -- VINCA ALKALOIDS -- MICROTUBULE ANTAGONISTS -- MITOTIC MOTOR PROTEIN INHIBITORS -- MECHANISMS OF RESISTANCE TO MICROTUBULE INHIBITORS -- 22 Kinase Inhibitors as Anticancer Drugs -- INTRODUCTION -- EARLY SUCCESSES: TAR GETING CANCERS WITH WELL-KNOWN KINASE MUTATI ONS (BCR-ABL, KIT, HER2) -- DIRECTLY TARGETING THE PI3K PATH WAY -- COMBINATIONS OF KINASE INHIBITORS TO INDUCT RESPONSE AND PREVENT RESISTANCE -- SPECULATI ONS ON THE FUTURE ROLE OF KINASE INHIBITORS IN CANCER MEDICINE -- 23 Histone Deacetylase Inhibitors and Demethylating Agents -- INTRODUCTION -- EPIGENETIC ABNORMALITIES AND GENE EXPRESSION CHANGES IN CANCER -- HISTONE DEACETYLASE INHIBITORS -- EPIGENETIC THERAPY FOR HEMATOLOGIC MALIGNANCIES -- NEW APROACHES TO EPIGENETIC THERAPY -- 24 Proteasome Inhibitors -- BIOCHEMISTRY OF THE UBIQUITIN-PROTEASOME PATHWAY -- PROTEASOME INHIBITORS -- PROTEASOME INHIBITORS IN CANCER -- 25 Poly (ADP-ribose) Polymerase Inhibitors -- INTRODUCTION -- CELLULAR DNA REPAIR PATHWAYS -- THE DEVELOPMENT OF PARP INHIBITORS -- BRCA1 AND BRCA2 MUTATIONS AND DNA REPAIR -- PARP -1 INHIBITION AS A SYNTHETIC LETHAL THERAPEUTIC STRATE GY FOR THE TREAT MENT OF BRCA -DEFICIENT CANCERS -- INITIAL CLINICAL RESULTS TESTING SYNTHETIC LETHALITY OF PARP INHIBITORS AND BRCA MUTATION -- THE USE OF PARP INHIBITORS IN SPORADIC CANCERS -- MECHANISMS OF RESISTANCE TO PARP INHIBITORS -- PROSPECTS -- 26 Miscellaneous Chemotherapeutic Agents -- HOMOHARRINGTONINE AND OMACETAXINE -- L-ASPARAGINASE -- BLEOMYCIN -- PROCARBAZINE. SIROLIMUS AND TEMSIROLIMUS -- VISMODEGIB -- ADO-TRASTUZUMAB EMTANSINE -- SIROLIMUS AND TEMSIROLIMUS -- EVEROLIMUS -- THALIDOMIDE, LENALIDOMIDE, AND POMALIDOMIDE -- 27 Hormonal Agents -- Introduction -- SELECTIVE ESTROGEN RECEPTOR MODULATORS -- AROMATASE INHIBITORS -- GONADOTROPIN-RELEASING HORMONE ANALOGS -- GONADOTROPIN-RELEASING HORMONE ANTAGONISTS -- ANTIANDROGENS -- NOVEL ANTIANDROGENS -- OTHER SEX STEROID THERAPIES -- OTHER HORMONAL THERAPIES -- 28 Antiangiogenesis Agents -- INTRODUCTION -- UNDERSTANDING THE ANGIOGENIC PROCESS -- DRUG DEVELOPMENT OF ANGIOGENESIS INHIBITORS -- CLINICAL UTILITY OF APPROVED ANTIANGIOGENIC AGENTS IN CANCER THERAPY -- COMBINATION THERAPIES -- BIOMARKERS OF ANTIANGIOGENIC THERAPY -- RESISTANCE TO ANTIANGIOGENIC THERAPY -- 29 Monoclonal Antibodies -- INTRODUCTION -- IMMUNOGLOBULIN STRUCTURE -- MODIFIED ANTIBODY-BASED MOLECULES -- FACTORS REGULATING ANTIBODY-BASED TUMOR TARGETING -- UNCONJUGATED ANTIBODIES -- ALTERING SIGNAL TRANSDUCTION -- IMMUNOCONJUGATES -- ANTIBODIES APPROVED FOR USE IN SOLID TUMORS -- ANTIBODIES USED IN HEMATOLOGIC MALIGNANCIES -- CONCLUSION -- 30 Assessment of Clinical Response -- INTRODUCTION -- ASSESSING RESPONSE -- ALTERNATE RESPONSE CRITERIA -- DETERMINING OUTCOME -- PART IV Cancer Prevention and Screening -- 31 Tobacco Use and the Cancer Patient -- Introduction -- NEUROBIOLOGY OF TOBACCO DEPENDENCE -- TOBACCO USE PREVALENCE AND THE EVOLUTION OF TOBACCO PRODUCTS -- TOBACCO USE BY THE CANCER PATIENT -- THE CLINICAL EFFECTS OF SMOKING ON THE CANCER PATIENT -- ADDRESSING TOBACCO USE BY THE CANCER PATIENT -- FUTURE CONSIDERATIONS -- 32 Role of Surgery in Cancer Prevention -- INTRODUCTION -- PATIENTS AT HIGH RISK FOR BREAST CANCER -- HEREDITARY DIFFUSE GASTRIC CANCER -- SURGICAL PROPHYLAXIS OF HEREDITARY OVARIAN AND ENDOMETRIAL CANCER -- HEREDITAR Y ENDOMETRIAL CANCER (LYNCH SYNDRO ME). GYNECOLOGIC CANCER RISK IN VERY RARE HEREDITARY CANCER SYNDRO MES. |
| Altri titoli varianti | Cancer : principles & practice of oncology |
| Record Nr. | UNINA-9910807121703321 |
| Philadelphia, : Wolters Kluwer Health/Lippincott Williams & Wilkins, 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Devita, Hellman, and Rosenberg's cancer : principles & practice of oncology / / editors, Vincent T. DeVita, Jr., MD, et al
| Devita, Hellman, and Rosenberg's cancer : principles & practice of oncology / / editors, Vincent T. DeVita, Jr., MD, et al |
| Edizione | [Tenth edition.] |
| Pubbl/distr/stampa | Philadelphia : , : Wolters Kluwer, , 2014 |
| Descrizione fisica | 1 recurso en línea |
| Disciplina | 616.99/4 |
| Soggetto topico | Tumors |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-4698-9455-6
1-4963-2467-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910459782003321 |
| Philadelphia : , : Wolters Kluwer, , 2014 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
DeVita, Hellman, and Rosenberg's cancer [[electronic resource] ] : principles & practice of oncology / / [edited by] Vincent T. DeVita Jr., Theodore S. Lawrence, Steven A. Rosenberg
| DeVita, Hellman, and Rosenberg's cancer [[electronic resource] ] : principles & practice of oncology / / [edited by] Vincent T. DeVita Jr., Theodore S. Lawrence, Steven A. Rosenberg |
| Edizione | [10th ed.] |
| Pubbl/distr/stampa | Philadelphia, : Wolters Kluwer Health/Lippincott Williams & Wilkins, 2014 |
| Descrizione fisica | 1 recurso en línea |
| Disciplina | 616.99/4 |
| Altri autori (Persone) |
DeVitaVincent T., Jr., <1935->
LawrenceTheodore S RosenbergSteven A |
| Soggetto topico |
Cancer
Oncology Neoplasms |
| ISBN |
1-4698-9455-6
1-4963-2467-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Cancer : principles & practice of oncology |
| Record Nr. | UNINA-9910787258303321 |
| Philadelphia, : Wolters Kluwer Health/Lippincott Williams & Wilkins, 2014 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||